Vivek Ramaswamy’s artful narrative, meticulously tailored for the GOP primary voter, weaves a tale of principled sacrifice and success. According to his version, he helmed the leadership of Roivant, a multi-billion-dollar American pharmaceutical company he founded, and gallantly relinquished his CEO role in 2021 due to his unwavering stance against ESG principles, despite facing opposition from his liberal workforce. While this narrative might seem appealing, it is akin to the endless “flip-flops” that have plagued his campaign—an elaborate work of fiction that unravels upon a modicum of scrutiny.

Newsweek